Nanobiotechnology-based treatment strategies for malignant relapsed glioma

Q Qiu, X Ding, J Chen, S Chen, J Wang - Journal of Controlled Release, 2023 - Elsevier
Gliomas are the most aggressive and lethal tumors of the central nervous system, for which
few therapeutic options exist. Surgical resection is the primary treatment for most gliomas; …

Neural stem cell therapy for cancer

JR Bagó, KT Sheets, SD Hingtgen - Methods, 2016 - Elsevier
Cancers of the brain remain one of the greatest medical challenges. Traditional surgery and
chemo-radiation therapy are unable to eradicate diffuse cancer cells and tumor recurrence …

Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

TM Kauer, JL Figueiredo, S Hingtgen, K Shah - Nature neuroscience, 2012 - nature.com
Therapeutically engineered stem cells have shown promise for glioblastoma multiforme
(GBM) therapy; however, key preclinical studies are urgently needed for their clinical …

Exosomes as a biomarker platform for detecting epidermal growth factor receptor–positive high-grade gliomas

SV Manda, Y Kataria, BR Tatireddy… - Journal of …, 2018 - thejns.org
OBJECTIVE High-grade glial brain tumors are often characterized by an elevated
expression of the tumorigenic epidermal growth factor receptor variant III (EGFRvIII). The …

Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative …

TJ Yun, CK Park, TM Kim, SH Lee, JH Kim, CH Sohn… - Radiology, 2015 - pubs.rsna.org
Purpose To explore the role of dynamic contrast material–enhanced magnetic resonance
(MR) imaging in the differentiation of true progression from pseudoprogression in patients …

[HTML][HTML] Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling …

L Yi, Y Cui, Q Xu, Y Jiang - Oncology reports, 2016 - spandidos-publications.com
The substrates and mechanisms of ubiquitin specific peptidase 7 (USP7) in glioma remain
unclear. Lysine‑specific demethylase 1 (LSD1) may undergo proteasomal degradation; …

True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion …

YS Song, SH Choi, CK Park, KS Yi… - Korean journal of …, 2013 - synapse.koreamed.org
Objective The purpose of this study was to differentiate true progression from
pseudoprogression of glioblastomas treated with concurrent chemoradiotherapy (CCRT) …

The sustained delivery of temozolomide from electrospun PCL-Diol-b-PU/gold nanocompsite nanofibers to treat glioblastoma tumors

M Irani, GMM Sadeghi, I Haririan - Materials Science and Engineering: C, 2017 - Elsevier
In the present study, the PCL-Diol-b-PU/Au nanocompsite nanofibers were fabricated via
electrospinning process during two different stages to load an anticancer temozolomide …

Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma

JR Bagó, GJ Pegna, O Okolie, M Mohiti-Asli, EG Loboa… - Biomaterials, 2016 - Elsevier
Engineered stem cell (SC)-based therapy holds enormous promise for treating the incurable
brain cancer glioblastoma (GBM). Retaining the cytotoxic SCs in the surgical cavity after …

Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival

Q Li, O Wijesekera, SJ Salas, JY Wang, M Zhu… - Clinical Cancer …, 2014 - AACR
Purpose: Glioblastoma is the most common adult primary malignant intracranial cancer. It is
associated with poor outcomes because of its invasiveness and resistance to multimodal …